About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
University of Alabama Medicine 2020 ASCO Highlights
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
2020 ASCO Update on CAR-T in Lymphoma: First CD19/22 Dual Targeting CAR-T, ALLO-501 & ALLO-647 in R/R LBCL/FL, Axi-Cel in R/R iNHL
By
University of Alabama Medicine 2020 ASCO Highlights
FEATURING
Amitkumar Mehta
By
University of Alabama Medicine 2020 ASCO Highlights
FEATURING
Amitkumar Mehta
122 views
August 25, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Videos
16:36
University of Alabama Medicine 2020 ASCO Highlights
UAB ASCO 2020 Updates on HIF Inhibitors in Advanced RCC: Does Belzut…
Feat.
A. Basu
13:07
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Highlights on Newly Diagnosed MM: KRd vs. VRd - Are There …
Feat.
S. Bal
05:17
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Highlights on Advanced NSCLC: What Is the Clinical Benefit…
Feat.
D. Das
06:56
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on EGFR+ mNSCLC: Should We Incorporate Osimertinib …
Feat.
D. Das
13:57
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO IMvigor 130 Bladder Cancer Updated Results: Does the Addit…
Feat.
L. Nandagopal
09:38
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Advanced RCC: Are We Over-Treating Patients With…
Feat.
L. Nandagopal
07:32
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Prostate Cancer: How Effective Is Enzalutamide i…
Feat.
L. Nandagopal
15:11
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on CP-CML: What Dose of Ponatinib Is Both Safe and …
Feat.
P. Vachhani
10:41
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on R/R AML: What AMG 330 Dosage Is Safe and Tolerab…
Feat.
P. Vachhani
08:27
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in Frontline AML: Does …
Feat.
P. Vachhani
07:10
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in AML: Are Aza/Ven/Ivo…
Feat.
P. Vachhani
08:08
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in Frontline AML: What …
Feat.
P. Vachhani
13:15
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in Myeloid Malignancies…
Feat.
P. Vachhani
12:24
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on mBC: Do Surgery and Radiation After Initial Syst…
Feat.
E. Stringer-Reasor
11:17
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on PIK3CA HR+ BC: Is Alpelisib Effective After CDK4…
Feat.
E. Stringer-Reasor
14:19
University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on CAR-T in Lymphoma: First CD19/22 Dual Targeting …
Feat.
A. Mehta
